㈜셀레믹스

Publications

Celemics’ Publications

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

British Journal of Cancer

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Oh HJ, Bae JM, Wen X, Jung S, Kim Y, Kim KJ, et al. p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Br J Cancer. 2019 Apr;120(8):797–805.

 

10.1038/s41416-019-0429-2